BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9794407)

  • 1. Regulation of mouse CD72 gene expression during B lymphocyte development.
    Ying H; Healy JI; Goodnow CC; Parnes JR
    J Immunol; 1998 Nov; 161(9):4760-7. PubMed ID: 9794407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter.
    Ying H; Chang JF; Parnes JR
    J Immunol; 1998 Mar; 160(5):2287-96. PubMed ID: 9498769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1.
    Reimold AM; Ponath PD; Li YS; Hardy RR; David CS; Strominger JL; Glimcher LH
    J Exp Med; 1996 Feb; 183(2):393-401. PubMed ID: 8627152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic structure and transcriptional regulation of the early B cell gene chB1.
    Goitsuka R; Mamada H; Kitamura D; Cooper MD; Chen CL
    J Immunol; 2001 Aug; 167(3):1454-60. PubMed ID: 11466365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
    Kozmik Z; Wang S; Dörfler P; Adams B; Busslinger M
    Mol Cell Biol; 1992 Jun; 12(6):2662-72. PubMed ID: 1375324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/Egr-1 binding site and a novel site termed the PyG box.
    Riva A; Wilson GL; Kehrl JH
    J Immunol; 1997 Aug; 159(3):1284-92. PubMed ID: 9233624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of BSAP repressor and activator functions on BSAP concentration.
    Wallin JJ; Gackstetter ER; Koshland ME
    Science; 1998 Mar; 279(5358):1961-4. PubMed ID: 9506950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor B-cell-specific activator protein is not involved in the IL-4-induced activation of the human IgE germline promoter.
    Albrecht B; Peiritsch S; Messner B; Woisetschläger M
    J Immunol; 1996 Aug; 157(4):1538-43. PubMed ID: 8759736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The murine Ig 3' alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP).
    Neurath MF; Strober W; Wakatsuki Y
    J Immunol; 1994 Jul; 153(2):730-42. PubMed ID: 8021508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes.
    Masten SA; Shiverick KT
    Biochem Biophys Res Commun; 1995 Jul; 212(1):27-34. PubMed ID: 7541987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
    Akerblad P; Sigvardsson M
    J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B cell-specific transcription factor BSAP regulates B cell proliferation.
    Wakatsuki Y; Neurath MF; Max EE; Strober W
    J Exp Med; 1994 Apr; 179(4):1099-108. PubMed ID: 7511679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).
    Singh M; Birshtein BK
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4392-7. PubMed ID: 8633077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation.
    Singh M; Birshtein BK
    Mol Cell Biol; 1993 Jun; 13(6):3611-22. PubMed ID: 8497273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
    Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
    EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter.
    Libermann TA; Pan Z; Akbarali Y; Hetherington CJ; Boltax J; Yergeau DA; Zhang DE
    J Biol Chem; 1999 Aug; 274(35):24671-6. PubMed ID: 10455134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I.29 mu B cell line.
    Qiu G; Stavnezer J
    J Immunol; 1998 Sep; 161(6):2906-18. PubMed ID: 9743352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD72-mediated suppression of human naive B cell differentiation by down-regulating X-box binding protein 1.
    Yamazaki T; Nagumo H; Hayashi T; Sugane K; Agematsu K
    Eur J Immunol; 2005 Aug; 35(8):2325-34. PubMed ID: 16047337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype.
    Usui T; Wakatsuki Y; Matsunaga Y; Kaneko S; Koseki H; Kita T
    J Immunol; 1997 Apr; 158(7):3197-204. PubMed ID: 9120274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5.
    Tierney R; Kirby H; Nagra J; Rickinson A; Bell A
    J Virol; 2000 Nov; 74(22):10458-67. PubMed ID: 11044090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.